Table 2 Characteristics of each group by timepoint.

From: Community-based diabetes prevention randomized controlled trial in refugees with depression: effects on metabolic outcomes and depression

Characteristic

Baseline

12 Month

15 Month

P-value

P-value

12 Month

15 Month

Panel A: Primary outcomes means (± SD) by time point

Depression

SS

27.5 ± 10.4

24.5 ± 7.9

25.5 ± 9.1

  

EWS

28.2 ± 9.2

25.1 ± 7.8

23.1 ± 7.3

.785

.043

EWS + MTM

29.6 ± 10.7

23.6 ± 8.1

23.0 ± 8.4

.184

.011

HbA1c %

SS

5.40 ± 0.43

5.57 ± 0.44

5.53 ± 0.49

  

EWS

5.55 ± 0.41

5.53 ± 0.35

5.55 ± 0.37

.154

.757

EWS + MTM

5.53 ± 0.46

5.47 ± 0.47

5.50 ± 0.47

.011

.189

Insulin resistance

SS

1.00 ± 0.52

0.97 ± 0.39

0.89 ± 0.47

  

EWS

0.90 ± 0.39

1.00 ± 0.43

0.93 ± 0.41

.221

.197

EWS + MTM

0.93 ± 0.36

0.91 ± 0.35

0.90 ± 0.34

.689

.544

Panel B: Other variables means (± SD) by time point

Hair cortisol

SS

2.53 ± 1.39

2.99 ± 1.33

2.99 ± 1.95

  

EWS

2.62 ± 1.13

2.77 ± 0.99

2.64 ± 1.29

.257

.176

EWS + MTM

2.64 ± 1.25

2.49 ± 1.18

2.49 ± 1.29

.051

.062

hsCRP

SS

0.86 ± 0.60

0.93 ± 0.61

0.84 ± 0.55

  

EWS

0.93 ± 0.63

0.83 ± 0.62

0.85 ± 0.57

.179

.825

EWS + MTM

1.05 ± 0.67

0.85 ± 0.55

0.89 ± 0.47

.096

.671

Waist circumference

SS

92.0 ± 17.3

88.4 ± 10.3

87.5 ± 10.3

  

EWS

89.1 ± 10.4

89.0 ± 10.6

89.0 ± 12.3

.306

.119

EWS + MTM

91.8 ± 10.1

88.9 ± 8.5

87.0 ± 8.4

.910

.536

Body mass index

SS

26.6 ± 4.3

26.8 ± 3.7

26.5 ± 5.3

  

EWS

27.2 ± 4.8

26.6 ± 4.5

26.2 ± 4.3

.556

.441

EWS + MTM

27.0 ± 3.2

26.5 ± 4.7

26.8 ± 3.5

.495

.665

Systolic BP

SS

123 ± 18.4

123 ± 15.5

122 ± 16.0

  

EWS

127 ± 21.9

124 ± 18.8

119 ± 15.4

.582

.115

EWS + MTM

127 ± 19.4

122 ± 15.8

120 ± 14.2

.261

.239

Diastolic BP

SS

80.7 ± 10.0

78.6 ± 11.1

76.0 ± 9.2

  

EWS

80.8 ± 11.5

78.3 ± 10.1

76.5 ± 9.4

.872

.860

EWS + MTM

81.4 ± 10.9

79.2 ± 8.2

76.1 ± 8.6

.906

.836

LDL

SS

112 ± 32.9

116 ± 30.9

112 ± 29.1

  

EWS

119 ± 31.1

115 ± 34.2

114 ± 32.3

.459

.907

EWS + MTM

115 ± 34.2

116 ± 34.6

113 ± 32.6

.794

.981

HDL

SS

53.7 ± 14.4

55.2 ± 13.5

53.7 ± 12.0

  

EWS

52.3 ± 17.5

53.9 ± 15.4

52.4 ± 14.6

.605

.672

EWS + MTM

52.8 ± 14.4

55.5 ± 13.8

55.6 ± 16.1

.757

.610

Total cholesterol

SS

191 ± 37.8

195 ± 36.1

191 ± 33.2

  

EWS

196 ± 33.7

193 ± 41.0

192 ± 37.7

.502

.932

EWS + MTM

196 ± 36.5

194 ± 40.9

191 ± 37.0

.644

.828

Triglycerides

SS

142 ± 69.1

133 ± 54.6

143 ± 105

  

EWS

129 ± 56.3

136 ± 69.7

137 ± 83.8

.490

.973

EWS + MTM

147 ± 85.1

124 ± 73.7

127 ± 64.5

.478

.173

  1. The p-values for 12 month and 15 month are testing the specific intervention group (EWS or EWS + MTM) versus the control group, consistent with the a priori data analysis plan.
  2. SS social services, EWS Eat, Walk, Sleep, EWS + MTM Eat, Walk, Sleep plus Medication Therapy Management, BP blood pressure, LDL low density lipoprotein, HDL high density lipoprotein, hsCRP high sensitivity c-reactive protein.
Back to article page